SUNNYVALE, Calif., Jan. 3, 2013 -- Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback